{
  "docId": "019de071-1bdd-70bb-9c61-980d0c38b663",
  "docSlug": "a4792f18c57ea3f4ba27e696a63520de",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.4148858,
  "pageNumber": 12,
  "pageCount": 40,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 30,
  "notes": "Slide presents two distinct drug portfolios with corresponding clinical trial results (DESTINY-Lung01 and TROPION-PanTumor01).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/12",
  "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663",
  "deckJsonHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663.json",
  "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.05,
        "y": 0.52
      },
      "kind": "chart",
      "text": "HER2+ NSCLC waterfall plot",
      "attrs": null,
      "subkind": "waterfall",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "067db267-1f17-4997-a04b-63c46ea10f9c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.05,
        "y": 0.31
      },
      "kind": "chart",
      "text": "HER2m NSCLC waterfall plot",
      "attrs": null,
      "subkind": "waterfall",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42271d0a-3696-445d-86fb-ae16c7d6bd1c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.42,
        "x": 0.53,
        "y": 0.44
      },
      "kind": "chart",
      "text": "TROPION-PanTumor01 waterfall plot",
      "attrs": null,
      "subkind": "waterfall",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f7dbfeb-16b0-4390-b513-e80de514e627",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.72
      },
      "kind": "paragraph",
      "text": "Planned trials: DESTINY-Lung02, DESTINY-Lung 03, TROPION-Lung01, TROPION-Lung02, TROPION-Lung04, TROPION-Lung05",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d42e92ff-ca13-431a-9286-fcc6bf5c933f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.81
      },
      "kind": "source-note",
      "text": "Antibody drug conjugate, Objective response rate, Post PD-1, HER2 mutated, NCCN, Trophoblast cell-surface antigen 2, Anaplastic lymphoma kinase wild type.",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "025c0424-1728-454f-b0f6-7d106b5589ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.26,
        "x": 0.69,
        "y": 0.36
      },
      "kind": "table",
      "text": "TROPION-PanTumor01 response table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a0f64e87-7ae1-4603-9662-1eaf368dbe83",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.35,
        "x": 0.04,
        "y": 0.19
      },
      "kind": "title",
      "text": "Significant activity across NSCLC",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "064e91f9-06f5-45bf-b826-63f9f61f1835",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.5,
        "x": 0.04,
        "y": 0.14
      },
      "kind": "title",
      "text": "Enhertu, datopotamab deruxtecan: ADC portfolio",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62271697-913b-46f4-90f5-08c4ea4781d8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 7,
      "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}